Cortexyme CRTX 深 滬
等待開盤 11-04 09:30:00 美东时间
1.95
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.95
- 總市值 7049.41万
- 52周最高 121.98
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.782
- 委 比 0.00%
- 總股本 3615.08万
- 歷史最高 121.98
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.782
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cre8 Enterprise Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Hong Kong-based Cre8 Enterprise Limited received a notice from Nasdaq indicating it no longer meets the $1 minimum bid price requirement for its Class A ordinary shares under Nasdaq Listing Rules 5550(a)(2). The notice has no immediate effect, but the company must regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days by April 1, 2026. If it fails to do so, additional time may be granted subject t...
10-06 20:30
CRISM Therapeutics Secures Shareholder Backing at AGM
The latest announcement is out from Amur Minerals ( ($GB:CRTX) ). CRISM Therape...
08-26 23:07
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics, a clinical-stage biotech company, announced the granting of inducement awards to three new employees, including options to purchase 26,350 shares with an exercise price of $9.98 under its 2018 Employment Inducement Incentive Award Plan. The options vest 25% on June 2, 2026, followed by three equal annual installments, fully vesting by 2029, with a 10-year term. The company is focused on pioneering cell therapy for autoimmu...
06-03 11:05
Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
Cartesian Therapeutics has啟動其Descartes-08的三期AURORA試驗，這是針對全身性重症肌无力的首款CAR-T療法。首位患者已入組，將評估其療效及安全性。Descartes-08無需預處理化療，適用於門診治療。該療法已在二期研究中展示出持久的應答，平均MG-ADL評分改善顯著。試驗將隨機對照，規模約100例患者，主要終點為三個月時的評分改善情況。公司หวัง藉此改進現有的MG治療方案，提供更安全、持久的選擇。
05-30 11:00
CRISM Director Increases Stake in Company
Amur Minerals ( ($GB:CRTX) ) has issued an update. CRISM Therapeutics Corporati...
04-07 18:53
CRISM Therapeutics Earns MHRA Innovation Passport
Amur Minerals (GB:CRTX) has released an update. CRISM Therapeutics Corporation ...
2024-09-02 15:24
CRISM Therapeutics Share Price Surges Unexpectedly
Amur Minerals (GB:CRTX) has released an update. CRISM Therapeutics Corporation ...
2024-07-03 23:50
Netflix, Disney, streamers in focus as Canada unveils new funding contribution
Netflix (NASDAQ:NFLX), Walt Disney (NYSE:DIS) and other streaming services were in the spotlight on Tuesday after a Canadian government agency unveiled a new funding contribution targeted at streaming...
2024-06-04 23:48
Cortexyme（纳斯达克股票代码：CRTX）和 Pharmacyte Biotech（OTCMKTS: PMCB）财务比较
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get...
2023-04-13 04:42
Contrasting Cortexyme (NASDAQ:CRTX) & Acumen Pharmaceuticals (NASDAQ:ABOS)
Cortexyme (NASDAQ:CRTX – Get Rating) and Acumen Pharmaceuticals (NASDAQ:ABOS – ...
2023-02-23 15:03
